Desert King Strengthens Its Role in Global Health at World Vaccine Congress 2026
Desert King participated in The World Vaccine Congress Washington 2026, one of the most relevant global events in the vaccine industry, reaffirming its commitment to developing sustainable and scalable solutions to address current and future global health challenges.
The company’s participation was led by Damian Hiley, Partner & Managing Director of Desert King, who opened the company’s presence at the event with a prominent presentation in the Global Health track.
Damian Hiley Leads Desert King’s Presence at the Congress
During the first day, focused on specialized sessions and strategic discussions, Damian Hiley delivered the presentation:
“From Forest to Finished GMP: Securing QS-21 Supply for Global Health Vaccines”
The presentation was part of the session “Adjuvants at Scale: Sustaining Global Demand,” focused on identifying innovative and collaborative solutions to advance vaccine development, overcoming historical barriers while addressing challenges related to access and equity in low-resource settings.
During his presentation, Hiley highlighted Desert King’s strategic role in securing the global supply of QS-21, one of the most relevant adjuvants for next-generation vaccines.
Current Capacity and Future Vision
Desert King emphasized that the company currently has the capacity to meet existing QS-21 demand, along with a clear roadmap to scale production in response to future global needs.
However, the main challenge lies not only in production capacity, but in anticipating demand. Early visibility, joint planning, and strong collaboration among ecosystem stakeholders are essential to defining realistic volumes and timelines, enabling timely action and ensuring supply when it is needed most.
Commitment to Innovation and Collaboration
Desert King’s presence at World Vaccine Congress 2026 also helped strengthen relationships with leaders, researchers, and organizations from around the world in a key forum to discuss the future of vaccines and accelerate progress in areas such as tuberculosis, malaria, and other priority diseases.
Through this participation, Desert King continues to strengthen its position as a strategic partner to the global pharmaceutical industry, delivering high-quality solutions based on natural saponins and a long-term vision focused on public health impact.
